AKT1 and Other metabolic disease: Studies have found that the anti-lipolytic effect of insulin can be adjusted through the AKT/PKA/HSL signaling pathway (Yin et al., 2019), and inhibiting excessive lipolysis of adipose tissue (Park et al., 2020) is an important way to treat metabolic diseases.